{
"id":"mk19_b_hm_q011",
"number":11,
"bookId":"hm",
"correctAnswer":"E",
"title":"Question 11",
"stimulus":[
{
"type":"p",
"hlId":"08753b",
"children":[
"A 46-year-old woman is evaluated following discovery of an elevated hemoglobin level. She is asymptomatic, her history is unremarkable, and she takes no medications."
]
},
{
"type":"p",
"hlId":"c82d68",
"children":[
"On physical examination, vital signs are normal. The spleen tip is palpable."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"51169d",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Erythropoietin",
"children":[
"Erythropoietin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"375342",
"class":"cell text l",
"children":[
"2 mU/mL (2 U/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f1fae6",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Hematocrit",
"children":[
"Hematocrit"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"6247b6",
"class":"cell text l",
"children":[
"51%"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f9867c",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Hemoglobin, blood",
"children":[
"Hemoglobin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"5f1b1c",
"class":"cell text l",
"children":[
"17 g/dL (170 g/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"2989c0",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Leukocyte count",
"children":[
"Leukocyte count"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"66bbd2",
"class":"cell text l",
"children":[
"7000/μL (7 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"fcac73",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Platelet count",
"children":[
"Platelet count"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"c1afd4",
"class":"cell text l",
"children":[
"750,000/μL (750 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L)"
]
}
]
}
]
}
]
}
]
},
{
"type":"p",
"hlId":"4a4aa0",
"children":[
"Genetic testing is positive for the ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" V617F mutation."
]
},
{
"type":"p",
"hlId":"468496",
"children":[
"Low-dose aspirin is started. Phlebotomy is scheduled."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"1e31fb",
"children":[
"Which of the following is the most appropriate additional management?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Hydroxyurea"
}
},
{
"letter":"B",
"text":{
"__html":"Imatinib"
}
},
{
"letter":"C",
"text":{
"__html":"Interferon-α"
}
},
{
"letter":"D",
"text":{
"__html":"Ruxolitinib"
}
},
{
"letter":"E",
"text":{
"__html":"No further management"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"752397",
"hvc":true,
"children":[
"Patients with primary polycythemia vera should be treated with low-dose aspirin and phlebotomy to a target hematocrit of less than 45% to reduce the risk of adverse cardiovascular events."
]
},
{
"type":"keypoint",
"hlId":"3bc7a1",
"hvc":true,
"children":[
"Patients with polycythemia vera and additional risk factors, including age older than 60 years or a history of thromboembolic event should receive cytoreductive therapy with hydroxyurea or interferon-α in addition to phlebotomy."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"e10cb5",
"children":[
"No further management is needed for this patient (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option E"
]
},
"). She has a hemoglobin level greater than 16 g/dL (160 g/L), a low erythropoietin level, and presence of the ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" V617F mutation that meet diagnostic criteria for polycythemia vera (PV). Some patients may be asymptomatic, with the diagnosis suspected by findings on routine complete blood counts; however, many patients have symptoms of fatigue, headache, or itching, particularly after a warm shower (aquagenic pruritus). Accompanying splenomegaly may present with abdominal fullness, reflux, or early satiety. Unless contraindicated, all patients with PV should undergo phlebotomy to maintain a hematocrit level less than 45% and be treated with low-dose aspirin to reduce the risk of adverse cardiovascular events. Additional management depends on risk stratification of the patient. This patient's age (<60 years) and lack of thrombosis history categorize her as low risk. Patients at low risk need no additional therapy."
]
},
{
"type":"p",
"hlId":"0d2c5b",
"children":[
"Cytoreductive therapy is added for patients with high-risk PV, which includes those older than 60 years or with a history of thrombosis. Cytoreductive options in PV include hydroxyurea and interferon-α (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Options A, C"
]
},
"). Ruxolitinib has also been shown to be an effective treatment in those who are intolerant of first-line agents or with resistant PV (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
"). Cytoreductive therapy can sometimes be considered in patients at otherwise lower risk who have significant symptom burden or who require frequent phlebotomy; this patient does not have significant symptoms, and her phlebotomy requirements have yet to be determined."
]
},
{
"type":"p",
"hlId":"27ec32",
"children":[
"Imatinib is a tyrosine kinase inhibitor that is used in chronic myelogenous leukemia (CML) (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
"). Although imatinib is effective in the treatment of ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BCR-ABL"
]
},
"–positive CML, it is not used for ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
"-positive PV."
]
}
],
"relatedSection":"mk19_b_hm_s2_3_2",
"objective":{
"__html":"Treat low-risk polycythemia vera."
},
"references":[
[
"Mesa RA, Jamieson C, Bhatia R, et al. NCCN guidelines insights: myeloproliferative neoplasms, version 2.2018. J Natl Compr Canc Netw. 2017;15:1193-1207. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28982745",
"target":"_blank"
},
"children":[
"PMID: 28982745"
]
},
" doi:10.6004/jnccn.2017.0157"
]
],
"hospitalist":false,
"hvc":true,
"peerComparison":{
"A":44,
"B":6,
"C":3,
"D":8,
"E":38
},
"hlIds":[
"08753b",
"c82d68",
"a462a3",
"51169d",
"375342",
"f1fae6",
"6247b6",
"f9867c",
"5f1b1c",
"2989c0",
"66bbd2",
"fcac73",
"c1afd4",
"4a4aa0",
"468496",
"1e31fb",
"752397",
"3bc7a1",
"e10cb5",
"0d2c5b",
"27ec32"
]
}